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intROductiOn
Atherosclerosis is a chronic immune-modulated patholog-
ical process affecting multiple vascular beds and leads to 
diseases that are a major cause of morbidity and mortality 
worldwide.1 Typically, atherosclerosis has slow progression 
and a long asymptomatic phase. In the later stages, athero-
sclerosis may manifest as either exertional symptoms due 
to luminal narrowing or sudden events related to plaque 
rupture. The latter may cause local occlusion, as occurs 
in myocardial infarction. Alternatively, sudden rupture of 
an atherosclerotic plaque may cause distal embolism. This 
is typically seen in ischaemic stroke distal to a proximal 
internal carotid artery plaque rupture.
Structural vascular imaging throughout the body has 
advanced rapidly. Certain morphological features of 
atherosclerotic plaques are associated with a higher risk 
of disease progression.2 Combining established imaging 
strategies with “smart” contrast agents and biological 
tracers allows us to obtain complementary assessments 
of biological activity within plaques. This carries the 
potential to improve our pathophysiological under-
standing, leading to better patient risk stratification and 
management.
This review will focus on the techniques available to image 
atherosclerotic disease. We will describe how certain 
modalities are well suited to image specific cardiovascular 
components. Finally, we will illustrate how studying biolog-
ical activity within plaque advances our ability to detect 
disease, assess risk and guide patient management.
BiOlOgy OF AtheROScleROSiS
Atherosclerosis is a multifocal immunoinflammatory 
condition of medium and large-sized arteries.3 Exposure 
to established risk factors, such as hypertension, hypercho-
lesterolaemia and smoking, creates a systemic environment 
that encourages endothelial dysfunction,4 oxidation of lipo-
proteins,5 production of free oxygen radicals6 and leuko-
cyte migration.7 Accumulation of oxidized lipoproteins 
within the vessel wall forms fatty streaks. Macrophages 
migrate across the endothelium to phagocytose these lipid-
rich proteins. The high intracellular cholesterol content of 
macrophages induces pathways of cell death. The resultant 
debris, along with necrotic endothelial and smooth muscle 
cells, forms the principal constituent of the lipid-rich core 
(Figure 1).8
Atherosclerotic plaques consist of necrotic debris contained 
by outward remodelling and a fibrous cap within the 
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ABStRAct
Atherosclerosis is a chronic immunomodulated disease that affects multiple vascular beds and results in a significant 
worldwide disease burden. Conventional imaging modalities focus on the morphological features of atherosclerotic 
disease such as the degree of stenosis caused by a lesion. Modern CT, MR and positron emission tomography scanners 
have seen significant improvements in the rapidity of image acquisition and spatial resolution. This has increased the 
scope for the clinical application of these modalities. Multimodality imaging can improve cardiovascular risk prediction 
by informing on the constituency and metabolic processes within the vessel wall. Specific disease processes can be 
targeted using novel biological tracers and “smart” contrast agents. These approaches have the potential to inform 
clinicians of the metabolic state of atherosclerotic plaque. This review will provide an overview of current imaging 
techniques for the imaging of atherosclerosis and how various modalities can provide information that enhances the 
depiction of basic morphology.
2 of 14 birpublications.org/bjr Br J Radiol;92:20180309
BJR  Syed et al
intimal surface. Vulnerable plaques are prone to rupture and 
have pathoanatomical features, such as large lipid-rich necrotic 
cores contained by a thin (<65 µm) macrophage-rich fibrous cap 
and microcalcification.9 In metabolically active plaques, macro-
phages accumulate in the fibrous cap and degrade the extracel-
lular matrix that is produced by vascular smooth muscle cells.7 
The necrotic core creates a microenvironment of hypoxia and 
stimulates angiogenesis.10
Calcium deposition in vessel wall inflammation occurs as a 
macrophage-mediated reparative response to oxidized lipid depo-
sition and endothelial dysfunction. However, rather than being a 
passive by-product of degradation, the process of vascular calci-
fication is active and controlled. Calcification in atherosclerosis 
primarily affects the intima. This is in contrast to medial calcifica-
tion typically observed in patients with diabetes or chronic kidney 
disease, which adopts a concentric transmural morphology.11 The 
initiation of vascular calcification occurs on a microscopic level 
(beyond the resolution of conventional imaging) and involves 
the deposition of calcium and phosphate-rich hydroxyapatite 
crystals.12 This early stage of “microcalcification” signifies intense 
biological activity and is associated with increased plaque vulner-
ability. In contrast, the larger established deposits of macroscopic 
calcification that ultimately develop are associated with plaque 
stability and a more quiescent phase of disease.
Vulnerable plaques have a thin fibrous cap that is devoid of 
vascular smooth muscle cells and exhibits intense macro-
phage recruitment.13 Rupture of the thin fibrous cap exposes 
the lipid-rich necrotic core to luminal flowing blood, initiating 
rapid and aggressive thrombosis that can cause vascular occlu-
sion. However, plaque rupture is frequently silent and subclin-
ical. Over time, vascular remodelling incorporates the exposed 
thrombus and the degree of stenosis may worsen.
Figure 1. Pathophysiology of atherosclerosis. Arterial cross-section showing that active atherosclerotic disease is characterized by 
intense biological activity resulting from macrophage infiltration in response to the subendothelial accumulation of oxidized lipo-
proteins. A cascade of events leads to cell death and the formation of a lipid-rich necrotic core. Localized hypoxia from the lipid-
rich core promotes αvβ3 expression and angiogenesis. Thinning of the fibrous cap results from macrophage infiltration and loss of 
vascular smooth muscle cells. Cell death around the necrotic core leads to microcalcification. This biologically active plaque is at 
high risk of rupture. In contrast, quiescent atherosclerotic disease represents chronic healed inflammation with positive remodel-
ling. Calcification of the fibrous cap adds stability. This quiescent plaque is at low risk of rupture.
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Angiogenesis and collateralization can partially compensate 
for reduced blood flow caused by increasingly stenotic vessels. 
However, if arterial disruption is rapid, this compensatory 
angiogenesis has had insufficient time to occur, and the resultant 
ischaemia is more severe. Thus, vulnerable plaque rupture may 
cause sudden arterial occlusion, loss of tissue perfusion and cata-
strophic end-organ infarction. Prompt therapeutic reperfusion is 
required to minimize irreversible tissue loss in a highly time-de-
pendent process.14
AnAtOMicAl iMAging
Anatomical imaging is diverse and flexible. The chief objectives 
are to detect luminal narrowing and characterize atherosclerotic 
plaque. Imaging also allows a global assessment of atheroscle-
rotic disease burden within the entire vascular territory. This 
information helps clinicians stratify the risk of future adverse 
events.
Catheter-based contrast angiography is the most frequently used 
method to image the coronary vessels. This is largely because of 
the high spatial and temporal resolution that can be obtained. 
Indeed, catheter angiography is also a platform for interven-
tion. However, catheter angiography alone merely provides a 
“lumenogram” of the coronary circulation. Plaque characteriza-
tion is possible but requires specialist equipment. Intravascular 
optical and ultrasound imaging allow the constituents of plaque 
morphology to be assessed in remarkable detail. These tech-
niques are an excellent choice to image high-risk patients who 
may require simultaneous intervention.
There is a need to identify adverse plaque features using non-in-
vasive imaging techniques. This is especially true in low- and 
medium-risk patient cohorts. Modern cardiovascular medicine 
has seen increased adoption of non-invasive imaging tech-
niques. Angiography by CT or MRI is safe and offers a reliable 
alternative to catheter angiography. These imaging modalities 
can simultaneously image the vessel wall and any surrounding 
atherosclerosis. Similarly, ultrasound can determine blood 
flow across a lesion to quantify stenosis. Spectral analysis and 
specialized contrast agents can characterize plaque at the same 
time. Non-invasive imaging may also improve clinical decision 
making. It separates diagnosis from intervention, thus allowing 
rational decision making by a multidisciplinary team.
Here we discuss the imaging techniques available to visualize 
morphological features of atherosclerotic vessels. We touch 
briefly on how these techniques can help characterize plaque.
Intravascular imaging
Intravascular imaging techniques have the benefit of capturing 
images from close proximity to the plaque, thus offering 
extremely high-resolution images.
Optical coherence tomography
Optical coherence tomography (OCT) provides exception-
ally detailed images of the fibrous cap using near infrared light 
delivered via a fibre optic wire (Figure 2C). The OCT catheter 
is positioned over a guidewire and a blood-free pool is created 
by injecting saline or contrast media. Using fast frequency 
domain analysis, OCT captures detailed images of the adjacent 
thin fibrous cap. The findings correlate well with histological 
features.15 High signals in the fibrous cap signify macrophage 
adherence and thrombus formation.16 These high resolution 
benefits need to be balanced against reduced tissue penetration 
which limits assessment of deeper plaque constituents. OCT is 
used clinically to detect vulnerable plaques and guide therapy 
in the coronary arteries.17,18 OCT is now being used for these 
purposes in carotid artery stenosis19 and peripheral vascular 
disease.20
Figure 2. Imaging of coronary atherosclerosis in a patient with non-ST elevated myocardial infarction. (A) Catheter angiography 
shows an irregular lesion in the proximal left anterior descending coronary artery (artery). (B) Transaxial view of the coronary 
lesion on CT (i) shows a complex plaque with calcified (white) and fibrofatty (°) plaque around a central lumen (*). (C) Optical 
coherence tomography detects a thin fibrous cap (arrow) and lipid pools (*). (D) Combined near infrared spectroscopy and 
intravascular ultrasound confirms high lipid burden within the plaque (yellow). (E) Centreline reconstruction of the left anterior 
descending artery visualizes calcification and plaque formation throughout the entire vessel. (F) 18F-Sodium fluoride positron 
emission tomography/ CT detects high uptake in the atherosclerotic plaque.
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Near infrared spectroscopy/intravascular ultrasound
Near infrared spectroscopy (NIRS) is another catheter-based 
invasive technique. NIRS does not require a blood free field and 
uses wave scatter to produce a gradient map corresponding to the 
probability of adjacent lipid (Figure 2D). The resultant lipid-core 
burden index (LCBI) describes the ratio of high lipid content in 
adjacent structures against the total study area. Modern probes 
are combined with intravascular ultrasound (IVUS) to provide 
structural context to the morphological data.21
IVUS is a more established and, consequently, cost-effective 
technique than OCT and NIRS. It packages a high-frequency 
ultrasound probe in a catheter that can directly visualize adja-
cent atherosclerotic plaque from within the lumen (Figure 2D). 
High-resolution greyscale images show the structure of athero-
sclerotic plaque and the adjacent vessel wall. Features of plaque 
components can be identified by analyzing the backscatter and 
can reliably reveal the lipid-rich necrotic core, calcification and 
fibrofatty plaque.22,23 Despite reasonable tissue penetration, 
IVUS lacks the spatial resolution to measure the thickness of the 
fibrous cap. Like conventional ultrasound, mineralized calcium 
deposits cast acoustic shadows, thereby obscuring underlying 
tissue detail.
NIRS/IVUS is well established in detecting and treating coronary 
disease.15,24 Its use has been validated to perform a similar func-
tion in the carotid25 and lower limb26 arteries.
Non-invasive imaging
Ultrasound
In superficial vessels, such as the carotid and limb arteries, duplex 
ultrasound combines structural and functional data to quantify 
the degree of stenosis caused by atherosclerotic plaque. The ratio 
of peak systolic velocity proximal and distal to suspected lesions 
is used to estimate the degree of stenosis. Ultrasound can be 
used to measure the total plaque area27 and the greyscale pixel 
intensity of atherosclerotic plaque images have been shown to 
correspond with histological features.28 Ultrasound is non-inva-
sive, radiation-free and portable. Hence, it is often used as the 
first-line imaging modality to quantify stenoses throughout the 
peripheral vascular tree.
The high resolution of ultrasound can differentiate components 
of the arterial wall in superficial vessels. Pathological prolifer-
ation of the intimal-medial layer is a sign of early subclinical 
plaque formation.29 Detecting this thickening using ultrasound 
can be used as a "window" to an individual’s global cardiovascular 
health. Indeed, increased IMT is associated with significantly 
increased risk of myocardial infarction, stroke and death.30
Contrast agents containing a homogenous suspension of inert 
gas microbubbles (e.g. SF6) administered in the venous space 
can highlight specific features of arterial atherosclerotic plaque. 
In the carotid arteries, microbubbles identify neovasculariza-
tion in culprit lesions with a sensitivity and specificity greater 
than 80%.31 In patients with abdominal aortic aneurysms, 
contrast-enhanced ultrasound provides real-time characteriza-
tion of luminal flow. Visualization of complications following 
endovascular repair, such as endoleaks, is feasible.19,32 The lack of 
ionizing radiation makes contrast-enhanced ultrasound an ideal 
modality for situations that require repetitive imaging.
Standardizing the ultrasound assessment of vascular beds reduce 
the risk of interobserver variability. Vessel assessment is not 
always possible if the view is obscured by densely calcifying 
atherosclerotic disease. Similarly, bone or gas overlying the target 
vessel prevents adequate visualization using ultrasound, limiting 
its use to easily arteries that are easily accessible.
Computed tomography
The use of CT angiography (CTA) is well established to assess the 
cardiovascular system. It is non-invasive and accessible. CTA has 
the added benefit of visualizing the entire vessel from its origin to 
target structure, even in tortuous vessels. Among its many appli-
cations, CTA has the spatial resolution to detect focal luminal 
stenoses and provide a global assessment of vascular disease. 
Owing to the short acquisition times of new generation CT scan-
ners, it is now possible to image the coronary vessels in great 
detail. Indeed, CTA is highly accurate in determining coronary 
stenosis severity and has been incorporated within many clin-
ical guidelines as the first-line imaging modality for individuals 
with suspected cardiac chest pain. CTA is used throughout the 
vascular tree. In the carotid arteries, CTA has a reported sensi-
tivity approaching 100% and specificity of 63% (95% confidence 
interval 25–88%) to detect a stenosis greater than 70%.22,33,34
Beyond the assessment of luminal stenosis, CT can characterize 
plaque morphology. Several high-risk plaque features such as 
positive remodelling, spotty calcification, high-attenuation 
fibrous plaques and low-attenuation lipid-rich necrotic plaques 
can be identified.35–37 The napkin-ring sign on centreline recon-
struction of the coronary vessels represents differentiation 
between the fibrous plaque and necrotic core.38 It is charac-
terized by a crescentic high attenuation pattern surrounding a 
low-attenuation atheromatous lesion distinct from the vessel 
lumen—a morphological pattern that mirrors plaque histology.
CT is particularly well suited to visualize vessel calcification. 
However, beam hardening in relation to densely calcified plaque 
causes blooming that exaggerates plaque size and obscure the 
lumen—particularly in small calibre vessels with a high burden 
of calcification. In acute disease, CT is unable to differentiate soft-
tissue components of a plaque. For instance, it is not possible to 
distinguish directly a stable fibroatheromatous lesion from acute 
plaque haemorrhage or thrombosis. Identification of the culprit 
plaque relies on a combination of radiological features along 
with the clinical presentation and pattern of end-organ damage.
Magnetic resonance imaging
Angiography using MRI is best suited to imaging large stable 
vessels such as the carotid arteries. Multicontrast MRI (T1 
weighted, T2 weighted, proton density) offers excellent soft tissue 
characterization. This allows the constituents of atherosclerotic 
plaque to be investigated without the need for ionizing radiation. 
These properties make MRI useful in the longitudinal studies of 
chronic cardiovascular diseases. Administration of gadolinium 
(Gd)-based contrast media improves image acquisition times 
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and provides further structural information outlining differences 
between the blood pool and vessel wall.39
Motion artefact near the heart makes imaging small vessels 
challenging. Advances in MRI have addressed this limitation. 
Accelerated image acquisition allows for a reduction of motion 
artefacts and noise.40 Bright-blood techniques use blood itself 
as an intrinsic contrast agent, thus reducing the requirement of 
gadolinium-based contrast agents. Now, a 1.5 T MRI machine 
can detect significant left main stem or three-vessel coronary 
disease in up to 94% of patients.41 Whilst image quality remains 
inferior to CT coronary angiogram, MRA can be useful in the 
assessment of coronary aneurysms and aberrant coronary 
ostia.42 Additionally T1 weighted imaging can be applied to the 
coronary arteries for the detection of intraluminal thrombus or 
intra plaque haemorrhage. MRI has the extra benefit of assessing 
cardiac dynamics along with myocardial perfusion and viability. 
Ongoing advances in cardiac MRI make it a promising imaging 
modality of the future.
In the carotid arteries, the superior soft tissue discrimination of 
MRI allows the measurement of the fibrous cap thickness and 
visualization of the necrotic core.43 The sensitivity to detect lipid-
rich cores can be further improved using Gd-based contrast 
media.44 Following an acute event, such as a transient ischaemic 
attack from an internal carotid artery plaque rupture, T1 weighed 
MRI can detect intraplaque haemorrhage and thrombus. This 
correlates with the risk of future ischaemic events.45,46 Higher 
field strengths reduce background noise and artefact. Calcium 
typically appears hypodense, whereas fibrous tissue has a low 
signal intensity on T1 and high signal intensity on T2 weighted 
images.
“Smart” contrast agent MRI
Ultrasmall paramagnetic particles of iron oxide (USPIOs) 
are 30 nm iron oxide nanoparticles stabilized with low-mo-
lecular-weight dextran. USPIOs accumulate in macrophages 
following phagocytosis and remain in the circulation for 
extended periods.47 Areas rich in USPIO-positive macrophages 
have a low-signal intensity on T2 and T2* weighted MRI.48 In 
the carotid arteries, USPIO accumulation within atherosclerotic 
lesions coincides with active plaque disease. These plaque exhibit 
intense macrophage infiltration.49 USPIO also accumulate with 
high affinity in areas of macrophage infiltration within abdom-
inal aortic aneurysms (Figure 3C).50 Using smart MRI contrast 
agents to detect cellular activity within the vascular bed carries 
immense promise. These techniques may ultimately lead to the 
detection of active plaques at risk of imminent events and allow 
preventative therapy.
Magnetic Resonance Spectroscopy
MR spectroscopy (MRS) combines the spatial imaging obtained 
from MRI with spectral analysis to detect the chemical compo-
sition and metabolic state of cardiovascular tissue. MRS is able 
to detect a range of atoms, including 1-Hydrogen (1H), 31-Phos-
phorus (31P), and 13-Carbon (13C).51In vivo carotid studies 
using MRS have successfully quantified cholesteryl esters within 
atherosclerotic plaque.46,52 Cholesteryl esters are the major 
class of lipids found in the lipid-rich necrotic core of vulnerable 
Figure 3. CT, MRI and PET in a patient with a juxtarenal abdominal aortic aneurysm. (A) Transverse view of the aneurysm as seen 
on CT shows a dilated aorta with thrombus. (B) T2 weighted MRI of the same aorta differentiates between the lumen (•), throm-
bus (*) and adjacent structures. (C) A parametric map of the difference in T2* MRI intensity before and after the administration 
of ultrasmall particles of iron oxide uptake shows high focal uptake in the anterior wall of the aneurysm (arrow). (D) The sagittal 
CT view delineates the morphology of the aneurysm. (E) 18F-Sodium fluoride PET shows uptake within the anterior aortic wall 
(arrows) detects areas of greatest vascular injury. (F) Superimposing PET over the CT confirms high 18F-Sodium fluoride uptake 
at the aneurysm neck and near the bifurcation (arrows). PET,positron emission tomography.
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plaques. The chemical composition of structures is obtained 
using a chemical shift imaging sequence to acquire spectra over 
and around the atherosclerotic plaque. MRS amplitudes for 
specific metabolites, such as lipids, are then interpreted as a ratio 
to the amplitude of intrinsic water.53,54 The final analysis allows 
detection and quantification of the lipid content of atheroscle-
rotic plaque.
MOleculAR iMAging
Biologically active atherosclerotic lesions are inherently unstable 
and prone to rupture.55 Targeted biological tracers enable posi-
tron emission tomography (PET) and single proton emission 
computed tomography (SPECT) to detect increased activity of 
specific disease processes, such as increased glycolytic activity or 
microcalcification.
Biological radiotracer molecules typically consist of two compo-
nents. One section has a ligand that targets sites of specific 
disease activity. The other component consists of a radioisotope. 
PET and SPECT scanners can detect the intensity and distribu-
tion of radiotracer activity following molecular engagement with 
target disease processes. PET has superior image definition and 
has gained popularity over SPECT.
Molecular imaging in cardiovascular medicine has made 
substantial advances recently with an ever-expanding array of 
biological tracers targeting different processes. Approaches to 
standardize quantification of radiotracer uptake has improved 
the reporting and reproducibility of results.56
Glucose and glycolysis
18F-Fluorodeoxyglucose (18F-FDG) is a glucose analogue. It is 
the most commonly used biological tracer in clinical practice. 
18F-FDG is taken up by metabolically active cells and its imme-
diate metabolite is trapped within the cell following phosphory-
lation. This allows the quantification of cellular glycolytic activity. 
In vascular inflammation, uptake of 18F-FDG is pronounced 
in smooth muscle cells, endothelial cells and macrophages.57 
Increased 18F-FDG uptake in carotid and coronary atheroscle-
rosis correlates with unstable plaques and those that exhibit 
histological features of vulnerability,58,59 including increased 
CD68 macrophage density.60
Since 18F-FDG reflects glycolytic activity, uptake is non-specific. 
This limits interpretation of 18F-FDG PET in structures adjacent 
to those with a high physiological affinity to glucose, such as the 
myocardium. In order to visualize 18F-FDG PET uptake in the 
coronary arteries, it is necessary to suppress myocardial uptake 
using a low-carbohydrate, high-fat preparatory diet. However, 
these attempts at myocardial suppression are ineffective in 
around a quarter of patients, rendering assessment of coronary 
plaque activity very challenging.61
Macrophages and inflammation
Tracers that target macrophages directly, such as the soma-
tostatin subtype 2 (SST2) receptor analogues, overcome 
the limitations caused by the poor specificity of 18F-FDG. 
Here, the combination of a somatostatin ligand with a 
DOTA- (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic 
acid) or NOTA- (1,4,7-Tricarboxymethyl-1,4,7-triazacyclo-
nonane) based “cage” has resulted in the development of various 
tracers. The cage houses a positron-emitting isotope, such as 
Gallium-68 (68Ga) or Copper-64 (64Cu). PET studies reveal that 
these agents exhibit preferential vascular uptake in patients with 
established cardiovascular risk factors and adverse Framingham 
risk scores.62
Histological comparison of carotid plaque with high63 
Ga-DOTA-TATE (1,4,7,10-tetraazacyclododec-
ane-N,N',N'',N'''-tetraacetic acid]-D-Phe,1 Tyr3-octreotate) 
uptake reveals selective binding of the radiotracer to CD68-posi-
tive macrophage-rich lesions. In a pilot study,63Ga-DOTA-TATE 
correctly identified metabolically active coronary and carotid 
lesions with good reproducibility and higher sensitivity than 
18F-FDG.64
Other tracers targeting macrophage activity include vascular 
cell adhesion molecule-1 (VCAM-1), 11C-choline and 18F-flu-
thymidine. Chief amongst these are translocator protein (TSPO) 
ligands (11C-PK11195), which are 18 kDa proteins expressed in 
the mitochondria of most cells. Activated macrophages exhibit 
marked upregulation of these translocator proteins. Preliminary 
studies suggest that 11C-PK11195 PET/CT correctly identifies 
suspected carotid lesions and has favourable tissue-to-back-
ground ratios compared to 18F-FDG.65
Activated inflammatory cells within atherosclerotic plaque 
exhibit CXCR-4 receptors. Novel PET radiotracers, such 
as63Ga-Pentaxifor, can be used to target these receptors.66 In 
the coronary arteries,63Ga-Pentaxifor is high in culprit vessels 
following acute myocardial infarction (median maximum stan-
dardized uptake value 1.96, interquartile range 1.55–2.31). These 
lesions also have high concentrations of CD68 +macrophages.67
Microcalcification
18F-Sodium fluoride (18F-NaF) binds to exposed hydroxyapatite 
crystals. Due to surface area effects, it preferentially binds to areas 
of developing microcalcification, which is beyond the resolution 
of CT.63,68 Because 18F-NaF is not taken up by myocardium, the 
background signal is low, which allows even relatively low signal 
to be visualized within the coronary vessels (Figure 2)—a signif-
icant advantage over 18F-FDG.
In vivo studies have demonstrated binding of 18F-NaF to areas 
of active calcification which are associated with plaque insta-
bility. Prospective studies have established high 18F-NaF uptake 
in culprit coronary69 and carotid plaques.69 In carotid plaque, 
the findings correlated strongly with histological features of 
high-risk plaques, including macrophage infiltration, necrosis 
and apoptosis. In culprit coronary vessels, high 18F-NaF uptake 
shows good agreement with high-risk features on intravascular 
ultrasound.69
The application of 18F-NaF PET/CT extends to vascular calci-
fication in the wider arterial tree. In a prospective study of 72 
patients with abdominal aortic aneurysms, there was marked 
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uptake of 18F-NaF within the wall of aneurysms compared to 
non-aneurysmal sections and the aorta of healthy controls. 
High 18F-NaF uptake suggested weakening of the aortic wall and 
greater aneurysm expansion or rupture.70 These findings draw a 
link between metabolically active abdominal aortic aneurysms 
and morphological disease progression.
Hypoxia and angiogenesis
18F-Flumisonidazole (18F-MISO) is a biological tracer that 
concentrates in hypoxic viable cells due to an accumulation of its 
metabolites in an oxygen-deprived environment. Animal models 
show 18F-MISO correlates well with aortic atherosclerosis and 
areas of FDG uptake.71 Exploratory human studies suggest 
that 18F-MISO PET/CT corresponds to areas of vessel hypoxia, 
increased macrophage density and 18F-FDG uptake in symptom-
atic carotid artery disease.68,72
Angiogenic endothelial cells and hypoxic macrophages in 
atherosclerotic plaque express αvβ3 integrin cell surface glyco-
proteins. In animal models, αvβ3 targeted imaging with MRI 
sensitive paramagnetic particles identify areas of angiogenic 
proliferation.73 A novel PET tracer, 18F-Galacto-RGD, can also 
target αvβ3 integrin74 and in mice models of atherosclerosis, 
binds to sites of new atherosclerotic plaque. However, histolog-
ical analysis in these mice models showed that uptake co-local-
ized in macrophage-rich atherosclerotic plaque, as opposed to 
angiogenesis specifically.75 Culprit carotid plaques demonstrate 
increased 18F-Galacto-RGD uptake on pre-operative PET/CT 
and post-operative autoradiography analysis. In a small sample 
of patients, 18F-Galacto-RGD binding showed a tendency to bind 
to plaque rich in macrophages and those with increased vasa 
vasorum density.76
clinicAl tRAnSlAtiOn
Anatomical imaging is part of routine clinical care. Advances in 
cardiovascular imaging now allow plaque characterization over 
and above the degree of vessel stenosis. Multimodality techniques 
enable in vivo detection of high-risk features and culprit plaques 
(Table 1). Biological PET tracers can detect and quantify specific 
disease processes before they manifest as structural changes or 
cause clinically significant events. Improved diagnosis, accurate 
risk prediction and targeted treatment remain a crucial objective 
in the management of atherosclerotic conditions.
Coronary artery disease
The clinical presentation of occlusive coronary disease is vari-
able. Contemporary imaging of the coronary vessels addresses 
two important objectives—the assessment of total plaque burden 
and the detection of end-organ ischaemia. Complementary 
imaging techniques can inform on the functional and metabolic 
state of atherosclerotic plaque. This adds a new perspective to 
plaque assessment beyond established imaging techniques.
The assessment of patients with stable chest pain highlights the 
evolving role of imaging to aid diagnosis. Traditionally, the risk of 
coronary artery disease was estimated using clinical risk predic-
tion tools. If a clinical diagnosis was suspected, exercise testing 
and myocardial perfusion studies were recommended. NICE 
amended its guidelines in 2016 to reflect the benefits offered by 
CT coronary angiography (CTCA) and now recommends CTCA 
Table 1. Imaging modalities to detect high-risk features of atherosclerotic plaque
High risk plaque 
feature
Optical 
imaging
Ultrasound 
scan CT MRI PET
Vessel stenosis or 
occlusion
OCT Duplex 
ultrasound scan
CT angiogram MR angiogram -
Thin fibrous cap OCT - - - -
Large necrotic core OCT, NIRS IVUS, virtual 
histology
Centre-line arterial 
reconstruction
T1 weighted high 
intensity plaque 
imaging
-
Angiogenesis 
and intraplaque 
haemorrhage
OCT Duplex 
ultrasound 
scan, IVUS, 
contrast 
enhanced 
ultrasound
- T1 weighted high 
intensity plaque 
imaging, αvβ3 targeted 
paramagnetic 
particles
18F-MISO, 18F-Galacto-RGD
Subclinical plaque 
rupture
OCT, NIRS Duplex 
ultrasound 
scan, IVUS
- T1 weighted high 
intensity plaque 
imaging
Novel fibrin and platelet targeted 
biotracers
Glycolytic activity - - - - 18F-FDG
Macrophage infiltration OCT - - USPIO 18F-DOTATATE, VCAM-1, 
11C-Choline, 18F-Choline,11C-
PK11195
Microcalcification - - - - 18F-Sodium Fluoride (NaF)
IVUS, intravascular ultrasound; NIRS, near infrared spectroscopy; OCT, optical coherence tomography; PET, positron emission tomography; USPIO, 
ultrasmall paramagnetic particles of iron oxide.
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as the first-line investigation in patients with stable chest pain of 
suspected cardiac origin. The SCOT-HEART trial showed that, 
in patients with stable chest pain, CTCA reclassifies the diag-
nosis of coronary artery disease in up to a quarter of patients and 
improves the accuracy of diagnosing angina.77 Indeed, the sensi-
tivity and negative predictive value of CTCA is 99% when using 
a cut-off of 50% stenosis.78 Hence, CTCA offers a reliable and 
low-risk approach to exclude significant coronary artery disease 
in low- and medium-risk groups.
Coronary stenosis alone does not predict the risk of future 
cardiovascular events. Instead, events appear most closely related 
to adverse plaque features and total burden: the more plaque 
you have, the more likely one will rupture and cause a myocar-
dial ischaemia.79 The coronary artery calcium (CAC) score is a 
non-contrast CT technique that estimates overall calcification 
in vascular beds. The CAC score provides an improvement in 
predicting future cardiovascular events in patients at medium 
risk of ischaemic heart disease (Framingham risk score >10%).80 
In particular, CAC scores capture patients at high risk, who 
would otherwise be incorrectly classified using traditional 
scoring methods.81
Multimodality imaging adds a further dimension to the assess-
ment of patients with chest pain. For instance, in patients with 
acute coronary syndrome, the lipid core burden index on NIRS 
independently predicts future cardiovascular events (Hazard 
ratio 1.19, 95% confidence ratio 1.07–1.32, p = 0.001).82 In the 
heart, PET has traditionally remained a challenging area due to 
the non-specific uptake of 18F-FDG by the surrounding myocar-
dium.69 However, uptake of 18F-NaF is more selective to regions 
of microcalcification. This makes it an ideal agent for studying 
the coronary arteries. In a study of 80 patients, 18F-NaF prefer-
entially bound to IVUS-confirmed culprit coronary plaques.69 
Similarly, a study of 119 participants showed that 18F-NaF PET/
CT findings correlated with underlying angina (p = 0.023), prior 
cardiovascular events (p = 0.016) and Framingham risk scores (p 
= 0.011).83 The predictive power of 18F-NaF to identify culprit 
coronary plaques is the focus of an ongoing prospective multi-
centre trial in patients with recent acute coronary syndrome 
and multivessel disease: the PRE18FFIR study (NCT02278211). 
Whether this can be enhanced by other novel radiotracers, such 
as 68Ga-DOTATATE,84 remains to be established.
Non-invasive multimodality imaging enables the detection of 
high risk features in vivo and promises improved risk predic-
tion. Such high-risk groups could be targeted for more intensive 
prophylactic therapy, such as the emerging proprotein convertase 
subtilisin/kexin Type 9 (PCSK9) inhibitors. However, the added 
value of such imaging will need to be established in prospective 
trials, such as the DIAMOND study (NCT02110303) where the 
benefit of dual antiplatelet therapy in patients with high coronary 
18F-NaF PET uptake is being assessed.
Carotid artery disease
Extracranial carotid plaque rupture results in acute thrombus 
formation that may occlude the internal carotid artery or be 
the lead point for dissection. The thrombus may embolize to 
the brain or the eye causing permanent tissue loss. The goal in 
treating carotid artery disease is to prevent future thromboem-
bolic events. Imaging the carotid arteries fulfils an important role 
in cerebrovascular risk prediction. The NASCET85 and ECST86 
studies showed the benefit of endarterectomy in symptomatic 
high-grade carotid artery stenosis.87 Ultrasound is the mainstay 
of risk stratification of symptomatic carotid artery disease.88
We now know that early surgical intervention following an 
index carotid artery event is important to reduce recurrent 
embolic episodes from carotid artery lesions. Patients may have 
tandem disease. This group was excluded from the original 
NASCET trials. Hence, many guidelines do not advocate duplex 
ultrasound as the sole imaging arbiter prior to surgery. CT and 
MR angiography have the benefit of overcoming vessel tortu-
osity and visualizing the entire artery.89 However, nearly a third 
of recurrent disabling or fatal strokes occur in patients with 
internal carotid artery stenosis less than 50%.86 Ultrasound, CT 
and MR are limited to studying the morphological features of 
atherosclerotic plaque. They cannot reliably predict future cere-
brovascular events in “low” risk groups with lesser degrees of 
stenosis.89
Additional imaging techniques, such as contrast-enhanced ultra-
sound, and multiparametric or USPIO-enhanced MRI, can iden-
tify unstable and culprit atherosclerotic plaque. Moreover, PET 
imaging with 18F-FDG or 18F-NaF PET can detect the biological 
activity of culprit plaques, with 18F-NaF in particular binding to 
culprit carotid lesions characterized by a lipid-rich necrotic core 
(Figure 4).69 The combination of PET/MRI offers a substantial 
improvement with the potential to assess simultaneously for 
flow, thrombus, lipid core, plaque rupture and necrotic unstable 
plaque with microcalcification.
The treatment of asymptomatic patients with carotid artery 
disease remains controversial.90 Similarly, there is no consensus 
on how to best treat symptomatic patients with internal carotid 
artery disease below the current threshold for intervention. 
Multimodal imaging has the potential to deliver this better 
risk prediction in a non-invasive and powerful manner. The 
SAFFIRE studies (NCT03215563 and NCT03215550) will 
assess the clinical significance of 18F-NaF PET/MRI in relation 
to plaque vulnerability, the requirement for surgery and clinical 
outcomes. This may lead to better risk stratification of patients 
with stroke permitting better selection for surgery: avoiding 
unnecessary carotid endarterectectomy whilst encouraging 
intervention in high-risk plaque below the current threshold for 
surgical intervention.
Aortopathy
The pathobiology of abdominal aortic aneurysms shares key 
features with atherosclerotic disease. Ultrasound scan remains 
the cornerstone of abdominal aortic aneurysm screening and 
surveillance. However, current prediction models rely on a single 
morphological measurement of anteroposterior diameter to 
prognosticate the risk of aneurysm rupture. In males, this diam-
eter is 55 mm91 although many advocate a lower threshold for 
females. Endovascular or open surgical repair is considered once 
aneurysms reach this threshold.92
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Some aneurysms may rupture at sizes smaller than 55 mm whilst 
others reach large dimensions without causing any harm. Like 
carotid artery disease, multimodality imaging may provide better 
risk stratification than ultrasound scan-derived diameter alone.
MRI signal intensity can characterize thrombus organization with 
high accuracy. A high T1-signal is seen in disorganized thrombus 
that is typically unstable.93 A series of 35 patients with abdom-
inal aortic aneurysms found that individuals with high thrombus 
T1 signal intensity were likely to exhibit twice as fast aneurysm 
growth compared to those with organized thrombus.94 It is 
uncertain whether thrombus formation accelerates aneurysm 
growth. One possible explanation is that organized thrombus is 
the product of chronic stable aneurysm morphology, whereas a 
rapidly growing aneurysm has a large turnover of thrombus that 
is inherently unstable.
Smart contrast agents such as USPIO can further characterize 
biological activity within the aneurysm wall. High aortic mural 
USPIO uptake localizes to areas of macrophage infiltration and 
reflects vessel wall inflammation. An increased burden of USPIO 
uptake is observed in aneurysms with faster rates of expansion.48 
In aneurysmal disease, 18F-NaF PET/CT detects aortic microcal-
cification. This is a common end point of multiple pathological 
processes ultimately leading to aortic degeneration. Increased 
18F-NaF uptake is associated with faster aneurysm growth and 
an increased risk of rupture or requiring repair, independent of 
aneurysm diameter.70
Timely intervention is invaluable prior to the catastrophic conse-
quences of aneurysm rupture. Conversely, better risk prediction 
may aid the decision of conservative aneurysm management in 
patients with major comorbidities. Much like carotid disease, 
multimodal imaging may provide useful insights into future 
risk and be a better guide for surgical intervention in patients 
with aneurysms above and below the current standard of care to 
consider intervention at a binary cut point of aneurysm diameter 
above 55 mm.
Peripheral vascular disease
Peripheral vascular disease is a heterogenous group of occlu-
sive arterial conditions involving the lower limbs. Atheroscle-
rosis primarily causes intimal calcification. In contrast, diabetes 
mellitus and chronic kidney disease cause arterial stiffness by 
enhancing transmural calcification of the medial layer of the 
artery. Both processes are initiated by microcalcification.
Arterial duplex, MR and CT angiogram can visualize the lumen 
in large vessels but may either over estimate or underestimate 
the degree of stenosis in narrower arteries, such as below the 
knee. For instance, calcification in these small vessels causes 
a blooming artefact in CT Angiograms that obscures the view 
of the lumen. When calcification is not present, a contrast-en-
hanced residual lumen can be over estimated in CT with voxels 
that are too large. Hence, diagnostic angiography remains the 
gold-standard to visualize luminal narrowing in the lower limbs 
owing to its high spatial resolution. This approach, however, does 
not image the arterial wall or inform on the biological activity 
within it.
18F-Fluoride binds with good affinity to femoral plaque and 
is better at detecting inflammation compared to 18F-FDG.95 
A study of 409 oncology patients undergoing 18F-NaF PET/
CT were incidentally found to have significant femoral artery 
18F-fluoride uptake. The degree of uptake correlated strongly 
with hypertension, hypercholesterolaemia, smoking habit, 
diabetes mellitus and prior cardiovascular events.96 The clinical 
progression of this uptake in longitudinal studies remains to be 
validated.
Figure 4.  18F-Sodium fluoride positron emission tomography and magnetic resonance angiography of a symptomatic right inter-
nal carotid artery lesion. (A) Combined 18F-Sodium fluoride positron emission tomography superimposed on MR angiogram 
localizes focal radiotracer uptake in the culprit right internal carotid artery plaque (arrow). (B) Surgical endarterectomy confirms 
a highly ulcerated lesion with positive remodelling and marked intimal irregularity.
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Drug evaluation
Multimodal imaging can provide objective surrogate end points 
to confirm target engagement and treatment efficacy in relatively 
modest-sized populations.
One example is the study of statins in cardiovascular disease. The 
effect of statins on atherosclerotic burden has been extensively 
investigated using invasive97–99 and non-invasive100–102 imaging 
techniques. Intravascular imaging using OCT and IVUS was 
used to study the effects of statins on atheroma in trials such as 
ASTEROID,97 ESTABLISH99 and REVERSAL.103 Similarly, MRI 
has been used to quantify the reduction in the lipid content of 
necrotic core after treatment with rosuvastatin at 1 and 2 years of 
follow-up.100,101 The ATHEROMA trial used USPIO-enhanced 
MRI to show a reduction in carotid plaque inflammation within 
3 months of starting atorvastatin.102
Imaging may be used to validate the effect of therapeutic inter-
ventions. The REMNANT trial studied the effect of thrombus 
aspiration from culprit plaques in patients with acute coro-
nary syndrome. The investigators used IVUS to quantify the 
percentage increase in lumen volume following thrombus aspi-
ration and showed that aggressive intervention was likely to 
result in successful stent deployment.104 Conversely, MRI and 
PET/CT have been used to determine a lack of clinical efficacy. 
The dal-PLAQUE study did not show a reduction in vessel wall 
inflammation using the CTEP inhibitor, dalcetrapib: an agent 
that is now known to be clinically ineffective.105
cOncluSiOn
Detailed structural and functional assessment of the vascular tree 
is possible with conventional imaging modalities. However, the 
promise of identifying vulnerable atherosclerotic plaque leading 
to cardiovascular events remains elusive. Multimodality cardio-
vascular imaging provides the clinician with valuable informa-
tion on the morphology and metabolic state of atherosclerotic 
diseases. Combining imaging modalities offers powerful tools to 
study specific disease processes in the context of diagnosis, risk 
prediction and targeted intervention.
A paradigm shift to move away from the assessment of stenosis 
severity alone is required. Detecting high-risk plaque features 
promises to reclassify low- and medium-risk individuals who are, 
in fact, at high risk of developing adverse cardiovascular events. 
Correctly identifying this group is the greatest unmet clinical need 
in contemporary cardiovascular imaging. Incorporating novel 
imaging techniques addresses the limitations of modern steno-
sis-driven approaches. Translating these wide range of imaging 
techniques into clinical practice is the next major advance in athero-
sclerotic plaque assessment. Ongoing research on the role of meta-
bolic imaging promises to detect and prognosticate cardiovascular 
disease progression. These studies will better inform the translation 
of novel imaging modalities to mainstream clinical practice.
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